The METTL3-IGF2BP3 axis facilitates OS progression by enhancing ID1 mRNA stability and expression, highlighting its potential as a therapeutic target.
Share your take
Add a clinician perspective alongside expert commentary.
Shu et al. (Fri,) studied this question.